Summary by Moomoo AI
Heart Test Laboratories, Inc., a Texas-based medical technology company, filed a Registration Statement on Form S-8 with the Securities and Exchange Commission (SEC) on February 26, 2024. The filing pertains to the registration of 9,332,195 shares of common stock for issuance under the company's 2023 Equity Incentive Plan. The plan is designed to offer and sell shares to employees as part of their compensation and includes shares that may return to the plan pool due to options expiring unexercised, shares withheld for tax obligations, or shares forfeited due to non-vesting. The company has incorporated by reference its financial documents previously filed with the SEC, including annual and quarterly reports. Heart Test Laboratories has also detailed its indemnification agreements for directors and officers, emphasizing the company's commitment to attracting and retaining qualified personnel. The registration statement includes various exhibits related to the company's agreements, bylaws, and previous SEC filings.